Vanguard disaggregates holdings; reports 0 shares of Ingevity (NGVT)
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 13 to a Schedule 13G/A reporting no beneficial ownership of Ingevity Corp common stock. The filing states 0 shares and 0% ownership after an internal realignment that disaggregated certain subsidiaries' holdings in reliance on SEC Release No. 34-39538. The signature block shows Ashley Grim, Head of Global Fund Administration.
Positive
- None.
Negative
- None.
Insights
Amendment records disaggregated reporting; Vanguard reports zero beneficial ownership.
The filing lists 0 shares and 0% beneficial ownership of Ingevity Corp common stock following an internal realignment and separate reporting by subsidiaries under SEC Release No. 34-39538. This is an administrative ownership reporting change rather than a market trade.
Interpretation depends on subsidiary filings: subsequent Schedule 13G/A or Form 13Fs from related Vanguard entities may show where holdings were reallocated. Cash‑flow treatment and any selling activity are not stated in the provided excerpt.
FAQ
What does The Vanguard Group's Schedule 13G/A amendment for NGVT mean?
Why does Vanguard report zero ownership of NGVT after the realignment?
Will this amendment show where Vanguard's NGVT holdings moved?
Who signed the Schedule 13G/A amendment for NGVT on behalf of Vanguard?